Thomas Ebeling Cullinan Oncology, Inc. (CGEM) insider trading activity
Thomas Ebeling is of Cullinan Oncology, Inc.. Currently has a direct ownership of 186,653 shares of CGEM, which is worth approximately $2.95 Million. The most recent transaction as insider was on Jun 10, 2024, when has been sold 18,450 shares (Common Stock) at a price of $13.0 per share, resulting in proceeds of $239,850. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
187K
0%
3M change
n/a
12M change
Total Value Held
$2.95 Million
Thomas Ebeling Transaction History
TE
Thomas Ebeling
Cambridge, MA